Call us today 212-583-0100

Press Releases

Please view the latest press from Enzo Biochem, Inc.

Date Details
Thursday December 08, 2016 ENZO Biochem Reports Improved First Quarter Results
Thursday December 01, 2016 ENZO Biochem Schedules Teleconference To Discuss First Quarter 2017 Results Friday, December 9, 2016 at 8:30 Am E.T.
Thursday October 13, 2016 ENZO Biochem Reports Strong 2016 Operating Results
Thursday October 06, 2016 ENZO Biochem Schedules Teleconference to Discuss Fourth Quarter 2016 and Full Year Results Friday, October 14, 2016 at 8:30 Am E.T.
Wednesday September 21, 2016 Enzo Biochem Announces New York State Health Department Approval of New Easily Adaptable, Cost Effective Cardiac Assay
Thursday July 07, 2016 Enzo Biochem’s Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc.
Tuesday June 28, 2016 Enzo Biochem Added To Russell 2000, Russell 3000 and Russell Global Indexes
Wednesday June 08, 2016 ENZO Biochem Announces New York State Approval of New Women’s Test Based on Proprietary Technology
Wednesday June 08, 2016 Enzo Biochem Reports Fiscal Third Quarter Results Enzo Clinical Labs Posts Another Quarter of Double Digit Growth
Friday June 03, 2016 Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2016 Results Wednesday, June 8, 2016 at 8:30 Am E.T.
Monday May 16, 2016 Enzo Biochem’s Life Sciences Unit Reaches $35 Million Patent Infringement Settlement in Delaware With Life Technologies Corporation
Thursday March 10, 2016 ENZO Biochem Submits Ampiprobe™ Based Assay Targeted At Women’s Health for Approval to New York State Department of Health
Wednesday March 09, 2016 ENZO Biochem Reports Increased Fiscal Second Quarter Results
Wednesday March 02, 2016 ENZO Biochem Schedules Teleconference to Discuss Second Quarter 2016 Results Thursday, March 10, 2016 at 8:30 Am E.T.
Tuesday January 26, 2016 ENZO Biochem Collects $7 Million From Court Approved Escrow Fund Closings
Wednesday January 06, 2016 ENZO Biochem Announces Patent Infringement Settlement with Agilent Technologies
Wednesday January 06, 2016 ENZO Biochem Updates Corporate Developments at Annual Shareholders Meeting
Wednesday January 06, 2016 ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies, Inc.

To view releases from previous years, select the year below that you would like to see. You may chose to view the latest news or reports dating back to 2003.